Corbus Pharmaceuticals Holdings, Inc. Finance Lease, Liability, to be Paid, Year Two
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Finance Lease, Liability, to be Paid, Year Two of $291.70 thousand as of 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo · last filed 2024-03-12
- 2023-12-31: Finance Lease, Liability, to be Paid, Year Two $291.70K.
- 2023-09-30: Finance Lease, Liability, to be Paid, Year Two $67.63K.
- 2023-06-30: Finance Lease, Liability, to be Paid, Year Two $134.24K.
- 2022-09-30: Finance Lease, Liability, to be Paid, Year Two $185.72K.
| Period end | Finance Lease, Liability, to be Paid, Year Two |
|---|---|
| 2023-12-31 | $291.70K 10-K · filed 2024-03-12 |
| 2023-09-30 | $67.63K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $134.24K 10-Q · filed 2023-08-08 |
| 2022-09-30 | $185.72K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $185.72K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $185.72K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |